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ABSTRACT
Patients with an upper motor neurone
syndrome (CP) suffer from many disabling
primary symptoms: spasms, weakness, and loss
of dexterity. These primary ’neurogenic’
symptoms often lead to secondary disabilities,
muscle contractures, and tertiary effects, bone
deformations. A common symptom of CP is
hypertonia, with the consequence that the
involved muscles remain in an excessively
shortened length for most of the time. As a
normal reaction of the muscle tissue, the number
of sarcomeres is reduced and the muscle fibers
shorten permanently: a contracture develops. A
possible second type of contracture is that
normal muscle lengthening along with bone
growth is affected. Current treatments for the
secondary effects include (1) reduction of muscle
force, (2)lengthening of the muscle fibers by
serial plaster casts, and (3)surgical lengthening
of tendons or aponeurosis. The choice of treat-
ment depends on the cause of the functional
deficit. Bone tissue also adapts itself to abnormal
forces, especially in the growth period. The
hypertonias or contractures of CP so may give
*Address for correspondence:
Institute of Human Movement Sciences
University of Groningen, PO Box 196
9700 AD Groningen, The Netherlands
Tel: (31) 50 363 2645; fax: (31) 50 363 2751
e-mail: a.l.hof@med.rug.nl
rise to bone malformations that interfere with
function (e.g. femur endorotation) or may reduce
the action of muscles by changing the lever arm
(e.g. ankle varus). Although prevention should
always be preferred, a timely surgical intervention
cannot always be avoided. The differences in
treatment for the various groups require and
justify an extensive laboratory investigation,
including EMG recordings in gait, measurement
of passive elastic properties, and long-term
observation of the hypertonia.
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INTRODUCTION
Adaptation and plasticity in the nervous system
is the main subject of this issue, but muscles,
tendons, and bones show these effects as well. In
contrast to the nervous system, however, the
adaptation and plasticity in muscle and bone
generally are detrimental and should be avoided,
minimized, or corrected as much as possible. The
case of cerebral palsy (CP) provides a good
illustration. The primary cause is purely neurologic:
brain damage from perinatal age. All other effects,
muscle and tendon shortenings and bone defor-
mations, are secondary. That does not imply that
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they are less important. In many cases, the
secondary effects are more crippling than the
original disease itself. As an illustration, the
problem of equinus gait will be considered. To
show the problems in CP, first the normal activity
of the ankle plantarflexors in walking will be
discussed.
Normal walking
The ankle plantarflexors comprise three
muscles of which the monoarticular soleus muscle
is the strongest. The gastrocnemius muscle,
divided into a medial and a lateral head, is
biarticular. It not only plantarflexes the ankle but
also flexes the knee. In walking, all three muscles
are strongly active in the stance phase (Fig. 1).
During stance, the force increases gradually from
early stance during foot dorsiflexion (second
rocker) to reach a maximum at the time of
contralateral heel contact. It then declines very
rapidly to zero at toe-off.
Maximum force is very considerable and
amounts to about three times body weight in normal
subjects. This is about 50% of the peak force that
can be generated by these muscles in top speed
running. In contrast, the plantarflexor activity in
the swing phase of walking is virtually zero. There
is a moderate dorsiflexor (tibialis anterior) activity
to keep the ankle flexed during swing.
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Fig. 1" Force and EMGs of the human plantarflexor muscles during walking at normal speed. Stance period is between the vertical
dashed lines. During stance, the major plantarflexors, soleus and both heads of gastrocnemius, all are active. Dorsiflexor
tibialis anterior (EMG drawn downward) is active in swing to keep the tbot from the ground. There is a short period of co-
contraction at the transition from swing to stance.CHANGES IN MUSCLES AND TENDONS 73
Primary effects ofCP
The primary effects of CP can be separated
into excess symptoms and deficit symptoms (Young
& Wiegner, 1987; Young, 1994; Becher, 2000). The
deficit symptoms are paresis, loss of dexterity, and
reduced ability to perform isolated movements. For
our discussion, the excess symptoms spasticity, co-
contraction, and hypertonia are the most important.
Both the spontaneous spasms and the cocontrac-
tion can cause hypertonia: an increased level of
muscle activity over very long times that cannot be
sufficiently counteracted by the antagonists.
In CP, biarticular muscles are usually more
affected than mono-articular muscles by hyper-
tonia and spasticity. In the example of the ankle
plantarflexors, therefore, the gastrocnemius may
be excessively active, even when it should be at
rest, whereas the tibialis anterior muscle (which is
much weaker anyhow) has reduced force. The foot
will then stay continually in the plantarflexed
position, with shortened triceps surae. This condition
is known as the equinus foot. During the stance
phase of walking, this has the effect that the
patient continually walks on his toes. In swing, the
ongoing ankle plantarflexion makes the effective
leg longer, which has to be compensated in some
way to avoid stumbling. The primary pathology of
CP can thus already lead to an equinus foot.
SECONDARY EFFECTS OF CP
Muscle fibers
Muscle fibers adapt quickly to changing
circumstances. There are three mechanisms.
1. The first mechanism is adaptation to force.
This is also known as the strength training
effect. When a muscle is activated maximally
for a short time a day, it will respond by
increasing strength. The fibers become thicker,
the number of parallel contractile filaments
increase, and muscle force increases. In
contrast, when a muscle is not used, as in
paresis, it is wasted very soon.
2. The second mechanism is adaptation in speed.
Muscle fibers can either be slow (type I) or
fast (type I). Many physiologists have studied
the development of these properties. These
properties are in part genetically determined,
but they express themselves only when the
correct activation patterns occur in daily life.
Motor units ’born to be fast’ require a ’fast’
stimulus pattem to become fast: a high firing
frequency in short periods of activity. The
abnormal activation of the muscles in CP has a
direct effect on the muscle fiber composition.
Activity is almost continuous and firing
frequencies are never high. The consequence is
that muscles become slower (Rose & McGill,
1998). Together with the spasticity, which
implies a reduced ability to suppress muscle
activation and with a possible weakening due
to atrophy, this slowness can result in a
considerably reduced ’modulation’ of muscle
force development.
3. The third mechanism in muscle is adaptation
in length. In the growing child, the bones
increase in length. The normal reaction of
muscle tissue is to increase in length as well.
This means that the number of sarcomeres in
series increases in a muscle fiber and it adapts
itself to the range of lengths it is subjected to.
This is a normal and physiological process.
However, when a muscle due to hypertonia is
continuously kept in a shortened position, the
muscle fibers may adapt to this decreased length
and become unable to lengthen to normal lengths.
This condition is termed a contracture. The course
of events is thus (Fig. 2) that abnormal motor
control leads to hypertonia, and a hypertonia
which cannot be counteracted by the antagonists74 A.L. HOF
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Fig. 2: Interaction of processes leading from cerebral palsy (CP) to contracture and body deformations.
leads to a state of continuous shortening of the muscle.
This active shortening can then result in a permanent
length adaptation, a contracture. When, for example, the
gastrocnemius generates so much force that the
antagonist tibialis anterior cannot adequately counteract,
the ankle will remain continuously in an equinus
position. This position can become fixed into a
contracture.
The chain of events can also run indirectly.
The same gastrocnemius hypertonia with a resulting
equinus can lead to a contracture of the soleus,
which is passively shortened, without being spastic
or hypertonic. Still another possibility is that the
contracture is the result of compensatory actions.
A gastrocnemius hypertonia may lead to equinus
and knee bending. To compensate for this, a
posture with flexed knees and hips (crouched gait)
is assumed, and a contracture of the hip flexors
may result.
Contracture
It is appropriate to discuss the mechanical
correlates of contracture here. A muscle-tendon
unit can mechanically be considered as a three-
component system (Fig. 3). The contractile
component, which can grossly be identified with
the muscle fibers, can develop force over a certain
range of lengths (Fig. 4, dashed line). The
maximum force depends on the level of activation.
Parallel to this element is a passive elasticity,
representing the connective tissue around and next
to the muscle fiber (Fig. 4, continuous line). Over
most of the range of lengths its force is low, but
beyond a certain limit, passive force increases very
steeply. This increase of force serves to protect the
contractile muscle fibers from overstretching.
In gastrocnemius and soleus, the muscle fibers
are very short: their length l. is some 4 to 6 cm.
The remainder of the length, /,,. of about 30 cm,
comprises aponeurosis and tendon. In the scheme
in Fig. 3, this is denoted as the series elastic
component (SEC). Both the active and the passive
force-length relations are displaced therefore to
lengths around about 30 cm, see Fig. 5. The force-
length relations at the left are those of muscle
fibers (with length 1.), those at the left for the
complete muscle-tendon unit, with length l l.+l.,..CHANGES IN MUSCLES AND TENDONS 75
Fig. 3:
F
SEC
Is
CC
PEC
(MTC)
Schematic diagram of the mechanical components of muscle. The contractile component (CC) with length lc represents the
length of the contractile muscle fibers. The muscle fibers and their associated connective tissue also have elastic properties,
the parallel elastic component (PEC). In a series with the muscle fibers are the tendon and aponeurosis, represented in the
series-elastic component (SEC), with length l.. In the human plantarflexors total length of the muscle -tendon complex is
about 30 cm, ofwhich l. is around 26 cm and lc only 4 cm.
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Force-length relations of CC (active force, dashed) and PEC (passive force, solid) for the human plantarflexors as a
function ofCC length lc. The active force is controlled in amplitude by the muscle activation, peak level can be between 0
and about 5000 N. The curves have been obtained from the same subject as from the walking recording of Fig. 1.76 A.L. HOF
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Force-length relations ofCC (active force, -) and PEC (passive force,) br the human plantarflexors as a function ofboth
CC length lc (at the left) and total muscle+tendon length (right). Right figure: the range of lengths during walking is indicated
by vertical lines (- -). The muscle+tendon figures at the right are somewhat inclined to the right, due to the compliance of the
series elastic component. Upper arrow: maximum required active force during stance. Lower arrow: remaining passive force
during swing. This force, together with the weight of the foot, is countereacted by the dorsiflexor muscles. In normal muscle,
the available active force is amply sufficient over the whole length range, while the. passive force is small.
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As Fig. 5, but now for a subject with a contracture. Both the active force and passive force-length relations are shifted to
shorter lengths. This has two consequences. First, the required active force is now available only at the shorter muscle lengths.
Second, the passive Force has so much increased that passive dorsiflexion is reduced. Both lead to an equinus (tiptoe) gait.CHANGES IN MUSCLES AND TENDONS 77
It should be noted that the tendon is somewhat
compliant: it is stretched at higher forces. This can be
seen from the less steep slope of the curves at the right.
Length changes due to the normal range of movements
in walking are also given in this figure. In normal
subjects, the passive force is low over the usual range of
movement and the active force is high. The maximum
force of three times body weight during walking can be
easily achieved in normal subjects. The low passive
force of the plantarflexors will be counteracted by active
force from the tibialis anterior. This muscle can generate
a force of up to about 800 N, which is amply sufficient
to dorsiflex the foot over the whole range.
When a contracture has developed, muscle
fibers have become too short because of a
diminished number of sarcomeres. This is reflected
in the active force-length relation, which has
become narrower and has shifted to the left (Fig. 6).
As long as the tendon length does not change, the
same can be seen at the joint. This results in a
decrease of the active range: the muscle cannot
generate high forces at dorsiflexed positions.
Together with the muscle fibers, connective
tissue also decreases in length. At the ankle, the
passive range of motion is diminished, and that is
what is usually measured in order to define a
contracture (Tardieu et al., 1982a,b). All these
effects have been studied and reproduced in
experimental animals (Tabary et al., 1972).
Several problems still remain, however. Why
do the muscle fibers adapt to decreased length and
not the tendon? The answer seems to be a matter
of time: muscle tissue adapts itself in the course of
weeks, but tendon does so in the course of months.
But eventually, the tendon should also increase in
length as a result of bone growth. Another
question is whether passive elasticity, a property
of connective tissue, always follows changes in
muscle fiber length. This is usually assumed, but
the reason why is unclear.
With the mechanical model as presented, it is
simple to assess the effect of a surgical procedure,
such as lengthening of the Achilles tendon (Fig. 7).
When the tendon is increased in length, the curves
move to the left. The good result is that the passive
force is reduced and the passive range improves.
The bad result can be that the active force is
strongly reduced, and that only part of the active
force-length relation is used now. These effects
become worse with increased lengthening. The
effect can be cumulative: with too much lengthening
the force becomes very low; the muscle is no
longer is use and the tendon, which should grow
and adapt to the muscle fiber, remains too thin and
too compliant. A more extensive discussion of
fasciotomy and the interaction of muscle fiber with
connective tissue in general can be found in
Huijing (1999).
Group II contractures
The contracture in the form as discussed above
is a consequence of a normal process of muscle
length adaptation in response to abnormal muscle
activation. This type is known as a Group
contracture (Tardieu & Tardieu, 1987). Another
type of conracture, Group II, has a different origin.
As a consequence of the CP, the normal process of
length adaptation can be deranged, meaning that
the muscle no longer ’grows with the bone’. The
exact mechanism of this neurogenic growth
disturbance is unknown, but it is a well known
clinical phenomenon. In this case, the muscles do
not become too short, but the bones become ’too’
long. This indicates two quite different pathways
leading to contractures.
The continuous tension, due to either the
hypertonia itself or to the contracture, finally can
lead to deformations of the skeleton. This is
especially true in the growing child. The problems
can be many: valgus or varus of the foot, malrota-
tions ofthe tibia or the femur, hip luxations, etc.
1Confusingly, Tardieu et ai. (1982) used the reversed
classification in an earlier paper.78 A.L. HOF
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The contracture has been corrected by 2 cm. Achilles tendon lengthening. The passive force has been much reduced, which
is beneficial but also the active force is reduced. When the lengthening has been excessive, this can lead to an inability to
walk.
THERAPY
Reduction of hypertonia
What can be done against these malformations
and maladaptations? Clearly, the best solution would
be prevention. For CP, this means to prevent or to
reduce the hypertonia and to correct the unequal
balance between antagonistic muscles. For this, a
number of therapies is available, but each has major
side effects.
The first category of treatment tries to reduce
spasms and spasticity by acting on the central
nervous system. Selective rhizotomy is a major
neurosurgical operation, in which the sensory roots
of the spinal column are partially transsected. This
operation may reduce the spasticity, i.e., the
exaggerated reflexes. Baclophen is a GABA
antagonist that can be applied intrathecally in the
spinal canal, by means ofan implanted pump. Both
these therapies are quite invasive and should only
be used in the most severe cases.
The second category of therapy aims at a
reduction of muscle force in selected muscles. A
permanent reduction can be attempted by a partial
destruction of the nerve endings, either by toxic
substances like phenol or alcohol or by heat, thermo-
coagulation. A problem is that the application
must be precisely at the motor endplates as the
treatment is not really specific. In principle, the
effect is permanent, but reinnervation may occur.
Injection with botulinum toxin has a similar
effect, but only temporary. This toxin very
selectively inhibits the endplates and is effective
during 3 to 6 months. After this period, new
endplates on the original muscle have formed. This
treatment is becoming increasingly popular because
it is selective, the site of injection is less critical,CHANGES IN MUSCLES AND TENDONS 79
and there are few side effects (Russmann et al.,
1997; Molenaers et al., 1999; Graham, et al., 2000).
All these treatments aim at a reduction of the
muscle force in the selected muscles. The
disadvantage is obvious" the active muscle force
needed for movement is reduced. This holds even
more for the drug Dantrium (Dantrolene sodium).
It can be taken orally and gives a generalized
reduction of muscle force. It works directly on the
actinmyosin crossbridges in muscles. However, it
aselectively weakens all muscles, including the
paretic muscles and the antagonists of hypertonic
muscles.
Redressing contractures
A second line of defense is trying to prevent or
to redress contractures as a consequence of
hypertonia. The physiotherapist, in the first place,
should be very alert to this problem. Suitable
exercises, inducing the child to use the full range
of motion in the joint at risk, may postpone more
drastic actions. An orthosis can be fitted to restrict
joint motion, or a casting can be applied to force
the joint so that the muscle is lengthened. When
the muscle kept for some time elongated, the
number of sarcomeres adapts itself to this longer
length. By way of the same adaptation in
sarcomere number that causes the problem, it thus
can be remedied. The joint angle can be
progressively changed in a number of steps (serial
casting). Casting during the night can, in some
cases, be sufficient.
It will be obvious that all these treatments are
effective only in the case of a Group I contracture.
When the case is Group II, when the contracture is
caused by an inhibited muscle growth, medication
to reduce muscle force is useless and casting does
not work. (It rather will give strong discomfort.) In
those cases, a timely series of surgical interventions
is the only possible option.
Surgical interventions
When contractures have developed and cannto
be redressed, and in the case of skeletal deformities,
only surgical interventions remain. These can be
divided into soft tissue operations, corrections of
contractures, and skeletal corrections.
In case of the equinus foot, mere lengthening
of the Achilles tendon, which was for many years
the favorite option in orthopedic surgery, is not the
optimum treatment. Often the gastrocnemius is
hypertonic and the soleus normal. A tendon
lengthening, therefore, would weaken the active
forces of both muscles. If the tendon is lengthened
too much, the remedy is worse than the disease. A
better option is a partial aponeurotomy of gastroe-
nemius only (Baumann, 1989). For a biarticular
muscle like the rectus femoris, transfer of the
distal tendon is also an option as this transforms
the muscle from a knee extensor into a knee flexor.
Finally, when skeletal deformations need
correction, surgery is the only option. The present
opinion is that all corrections are best performed in
a single major operation, bones together with the
soft’ tissues, the so-called multilevel surgery (Nene
et al., 1993).
DIAGNOSIS
In order to select the optimal treatment for
maladaptation in muscles, tendons, and skeleton, a
careful diagnosis is needed. The first question is
which muscles are hypertonic. That is, which
muscles show an exaggerated or badly timed
activity, such that there is a danger of contracture.
Next to the clinical examination, which should
include a movement observation, an instrumented
gait analysis is necessary. In our opinion, an EMG
recording, which can show abnormal muscle activity
patterns, can be especially helpful. The diagnostic8O A.L. HOF
problem is not easily solved, however, as it can be
quite difficult at times to discriminate between
abnormal or spastic activity and compensatory
activity. Compensatory activity is in itself abnormal,
different from the normal pattem, but it is a sensible
action of the individual to correct for other
deficiencies. It is certainly a mistake to treat the
involved muscles with botulin toxin or to operate
their tendons. When the actual reason of the
compensation is remedied, the compensation itself
is no longer needed and will disappear by itself.
The second question is which muscles already
have developed a contracture? It is not easy to
discriminate between a muscle that is shortened
due to hypertoniaabnormally high activity--or
to an already developed contracturea high
passive stiffness. The distinction is quite important
for the treatment, however. Hypertonia can be
treated with botulin, a contracture might be
corrected with a casting. The clinical examination,
mainly the assessment of the passive range of
motion, is usually not sufficient. An EMG gait
recording can be helpful. The best and most direct
option is a recording of the moment-angle curve,
together with the EMG (Tardieu et al., 1982a, b;
Tardieu & Tardieu, 1987; Becher et al., 1998). In
that case, the passive stiffness is determined quanti-
tatively, and whether there is muscle activity can be
verified.
When a contracture had already developed, a
final discrimination in the diagnosis should be
made between a Tardieu Group and Group II
contracture. A difference is that in Group there is
an underlying hypertonia and in Group II there is
not. If, according to observations of both the
therapist and the parents, there are no spasms or
abnormal contractions at day or night, the disorder
might be of Group II, contracture due to growth
deficit. In such a case, casting is useless, and the
only option is a series of operations. In practice,
the differentiation is not that easy, and the final
proof is often the effect of casting: if a casting has
no effect, the patient probably suffers from a Group
II contracture.
CONCLUSION
The conclusions from this brief review can be
short and simple. First, prevention is better than
cure. Only in part of the cases it will be possible to
prevent contractures or skeletal deformations, but
every effort should be made to try. In our opinion,
this can only be done when CP children are
followed and supported a frequent intervals from a
very early age.
Secondly, it should be clear that good
diagnostic instruments are important to guide treat-
ment. Observations of movements and a clinical
examination of the range of movement are
necessary, but they are not sufficient to plan a
longtime casting procedure or a multilevel operation
with far-reaching consequences.
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